← Back to screener

Ingevity Corp NGVT

Rank #1694 · NYSE · $2.6B market cap
Audited by PricewaterhouseCoopers LLP, no going-concern flag in the latest filing.
Score
44.1
P/E
-478.6
P/B
3.70
ROE
-0.8%
Op. Margin
34.8%
Debt Ratio
262%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★☆☆☆
Weak

P/E -478.6x, P/B 3.70x. Ranks in the top 62% of the universe.

Profitability ★★★☆☆
Good

ROE -0.8%. Ranks in the top 38% of the universe.

Safety ★★☆☆☆
Weak

Debt ratio 262%. Ranks in the top 68% of the universe. Above 200% signals meaningful leverage risk.

Growth ★☆☆☆☆
Poor

Revenue decline of 27.1% year over year. Ranks in the top 94% of the universe.

Profitability is the relative strength · Growth is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2016–$0.2B$0.1B$0.5B–51
2017–$0.2B$0.1B$0.1B–550
2018$0.9B$0.2B$0.0B$0.3B18.0247
2019$1.0B$0.2B$0.1B$0.1B25.0725
2020$1.1B$0.3B$0.2B$0.3B28.3580
2021$1.3B$0.4B$0.2B$0.3B30.7500
2022$1.2B$0.4B$0.2B$0.5B32.7338
2023$1.4B$0.4B$0.1B$0.6B30.3317
2024$1.7B$0.5B$0.2B$0.7B27.1296
2025$1.2B$0.4B$-0.0B$0.7B34.8262

← See the full screener